Exploration of first onsets of mania, schizophrenia spectrum disorders and major depressive disorder in perimenopause

被引:0
|
作者
Lisa M. Shitomi-Jones [1 ]
Clare Dolman [2 ]
Ian Jones [1 ]
George Kirov [3 ]
Valentina Escott-Price [1 ]
Sophie E. Legge [1 ]
Arianna Di Florio [1 ]
机构
[1] Cardiff University,Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine
[2] Bipolar UK,National Centre for Mental Health, School of Medicine
[3] Cardiff University,undefined
来源
Nature Mental Health | 2024年 / 2卷 / 10期
关键词
D O I
10.1038/s44220-024-00292-4
中图分类号
学科分类号
摘要
Although the relationship between perimenopause and changes in mood has been well established, knowledge of risk of a broad spectrum of psychiatric disorders associated with reproductive aging is limited. Here we investigate whether the perimenopause (that is, the years around the final menstrual period (FMP)) is associated with increased risk of developing psychiatric disorders compared with the late reproductive stage. Information on menopausal timing and psychiatric history was obtained from nurse-administered interviews and online questionnaires from 128,294 female participants within UK Biobank. Incidence rates of psychiatric disorders during the perimenopause (4 years surrounding the FMP) were compared with the reference premenopausal period (6–10 years before the FMP). The rates were calculated for major depressive disorder (MDD), mania, schizophrenia spectrum disorders and other diagnoses. Overall, of 128,294 participants, 753 (0.59%) reported their first onset of a psychiatric disorder during the late reproductive stage (incidence rate 1.53 per 1,000 person-years) and 1,133 (0.88%) during the perimenopause (incidence rate 2.33 per 1,000 person-years). Compared with the reference reproductive period, incidence rates of psychiatric disorders significantly increased during the perimenopause (incidence rate ratio (RR) of 1.52, 95% confidence interval (CI) 1.39–1.67) and decreased back down to that observed in the premenopausal period in the postmenopause (RR of 1.09 (95% CI 0.98–1.21)). The effect was primarily driven by increased incidence rates of MDD, with an incidence RR of 1.30 (95% CI 1.16–1.45). However, the largest effect size at perimenopause was observed for mania (RR of 2.12 (95% CI 1.30–3.52)). No association was found between perimenopause and incidence rates of schizophrenia spectrum disorders (RR of 0.95 (95% CI 0.48–1.88)). In conclusion, perimenopause was associated with an increased risk of developing MDD and mania. No association was found between perimenopause and first onsets of schizophrenia spectrum disorders.
引用
收藏
页码:1161 / 1168
页数:7
相关论文
共 50 条
  • [41] INTERFERON RESPONSES IN SCHIZOPHRENIA AND MAJOR DEPRESSIVE-DISORDERS
    INGLOT, AD
    LESZEK, J
    PIASECKI, E
    SYPULA, A
    BIOLOGICAL PSYCHIATRY, 1994, 35 (07) : 464 - 473
  • [42] The financial situation before and after first-time psychiatric in-patient diagnosis of schizophrenia spectrum, bipolar, and major depressive disorder
    Eliason, Marcus
    ECONOMICS & HUMAN BIOLOGY, 2023, 49
  • [43] Efficacy of milnacipran for depressive symptoms in schizophrenia spectrum disorders
    Nakanishi, S
    Kunugi, H
    Takahashi, T
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2004, 58 (02) : 226 - 227
  • [44] Inflammatory cytokines in and cognitive function of adolescents with first-episode schizophrenia, bipolar disorder, or major depressive disorder
    Chen, Mu-Hong
    Hsu, Ju-Wei
    Huang, Kai-Lin
    Tsai, Shih-Jen
    Tu, Pei-Chi
    Bai, Ya-Mei
    CNS SPECTRUMS, 2023, 28 (01) : 70 - 77
  • [45] A comparison of psychotic phenomena in bipolar disorder, major depressive disorder and schizophrenia
    Toh, W. L.
    Thomas, N.
    Rossell, S.
    BIPOLAR DISORDERS, 2016, 18 : 119 - 119
  • [46] Intelligence decline across major depressive disorder, bipolar disorder, and schizophrenia
    Ohi, Kazutaka
    Takai, Kentaro
    Sugiyama, Shunsuke
    Kitagawa, Hiromi
    Kataoka, Yuzuru
    Soda, Midori
    Kitaichi, Kiyoyuki
    Kawasaki, Yasuhiro
    Ito, Munechika
    Shioiri, Toshiki
    CNS SPECTRUMS, 2022, 27 (04) : 468 - 474
  • [47] Molecular genetic overlap in bipolar disorder, schizophrenia, and major depressive disorder
    Schulze, Thomas G.
    Akula, Nirmala
    Breuer, Rene
    Steele, Jo
    Nalls, Michael A.
    Singleton, Andrew B.
    Degenhardt, Franziska A.
    Noethen, Markus M.
    Cichon, Sven
    Rietschel, Marcella
    Mcmahon, Francis J.
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2014, 15 (03): : 200 - 208
  • [48] First major depressive disorder and sexual dysfunctions
    Kachouchi, A.
    Akammar, S.
    Salim, S.
    Adali, I
    Manoudi, F.
    Asri, F.
    SEXOLOGIES, 2019, 28 (04) : 211 - 217
  • [49] TRAZODONE-INDUCED MANIA FOLLOWING DESIPRAMINE-INDUCED MANIA IN MAJOR DEPRESSIVE-DISORDERS
    ARANA, GW
    KAPLAN, GB
    AMERICAN JOURNAL OF PSYCHIATRY, 1985, 142 (03): : 386 - 386
  • [50] Thought disorder in subjects with schizophrenia spectrum disorders
    Koistinen, P
    Wahlberg, KE
    AniasTanner, H
    Keskitalo, P
    Tarvainen, T
    Moring, J
    Hakko, H
    Wynne, LC
    Tienari, P
    SCHIZOPHRENIA RESEARCH, 1997, 24 (1-2) : 133 - 133